This translation is provided for general access and has no recorded medical-language review.
General medical information
This page provides only a general scope and sources for Information on Botulinum Toxin Procedures. Personal suitability, the product or device used, potential benefit, risks, alternatives and the option of no procedure require a physician examination.
Online content is not diagnosis, prescribing, personal risk assessment or a treatment plan. A reference list is not a clinical sign-off; product and device information must also be checked against current Turkish registration and instructions for use.
These sources are editorial starting points. Each may be limited to a specific product, method, indication or study population.
Source titles remain in their publication language. Localized notes summarize the interpretation boundary and do not replace the full text. This translation has no recorded clinical or medical-language review.
U.S. Food and Drug Administration (FDA) · 2024 · Regulatory product information
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.
Editorial source — not a clinical sign-off record
Alaa Safia, Uday Abd Elhadi, Shlomo Merchavy, Ramzy Batheesh, Naji Bathish · 2026 · Systematic review and meta-analysis
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.
Editorial source — not a clinical sign-off record
David Zargaran, Florence Zoller, Alexander Zargaran, Eqram Rahman, Alexander Woollard, Tim Weyrich, Afshin Mosahebi · 2022 · Systematic review and meta-analysis
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local product or device information.
Editorial source — not a clinical sign-off record
Source-backed general information
Botulinum toxin targets nerve–muscle signaling, while dermal filler targets volume or support in soft tissue. They are different product groups and are not automatically interchangeable.
Botulinum toxin products are not identical. Formulation, authorized use, instructions and unit values are assessed for the exact product; an online number is not a personal plan.
Neuromuscular conditions, previous reactions, medicines and recent procedures can change the safety assessment. Botulinum toxin products, authorised uses and units are not interchangeable; area and dose require an individual assessment.
Contraindications, warnings, precautions and possible adverse effects are not the same; current information must be read for the exact product. Botulinum toxin products, authorised uses and units are not interchangeable; area and dose require an individual assessment.
Onset and duration depend on product, area, muscle activity, assessment timing and individual factors; one number of days is not a guarantee. Botulinum toxin products, authorised uses and units are not interchangeable; area and dose require an individual assessment.
Jaw appearance, clenching symptoms and the masseter muscle are not one problem; diagnosis, anatomy and the product's current indication are separate questions. Botulinum toxin products, authorised uses and units are not interchangeable; area and dose require an individual assessment.